SG10201800447UA - Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation - Google Patents

Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation

Info

Publication number
SG10201800447UA
SG10201800447UA SG10201800447UA SG10201800447UA SG10201800447UA SG 10201800447U A SG10201800447U A SG 10201800447UA SG 10201800447U A SG10201800447U A SG 10201800447UA SG 10201800447U A SG10201800447U A SG 10201800447UA SG 10201800447U A SG10201800447U A SG 10201800447UA
Authority
SG
Singapore
Prior art keywords
granules
rifapentine
isoniazid
preparation
pharmaceutical composition
Prior art date
Application number
SG10201800447UA
Inventor
Prajapati Dilip
Prasad Kum
Khullar Praveen
Kumar Ramesh
Kumar Shakti
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51211797&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201800447U(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of SG10201800447UA publication Critical patent/SG10201800447UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SG10201800447UA 2013-07-26 2014-07-22 Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation SG10201800447UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3341CH2013 2013-07-26

Publications (1)

Publication Number Publication Date
SG10201800447UA true SG10201800447UA (en) 2018-02-27

Family

ID=51211797

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201510730UA SG11201510730UA (en) 2013-07-26 2014-07-22 Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
SG10201800447UA SG10201800447UA (en) 2013-07-26 2014-07-22 Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201510730UA SG11201510730UA (en) 2013-07-26 2014-07-22 Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation

Country Status (18)

Country Link
US (1) US20160158157A1 (en)
EP (1) EP3024443A1 (en)
JP (1) JP6461142B2 (en)
CN (1) CN105407875A (en)
AU (1) AU2014295098B2 (en)
CA (1) CA2918827A1 (en)
CL (1) CL2016000182A1 (en)
EC (1) ECSP16005208A (en)
HK (1) HK1218862A1 (en)
IL (1) IL243368A0 (en)
MX (1) MX2016001154A (en)
PE (1) PE20160520A1 (en)
PH (1) PH12016500120A1 (en)
RU (1) RU2682178C2 (en)
SG (2) SG11201510730UA (en)
TW (1) TWI651084B (en)
WO (1) WO2015011161A1 (en)
ZA (1) ZA201600109B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2918828A1 (en) 2013-07-26 2015-01-29 Sanofi Antitubercular composition comprising rifampicin, isoniazid, ethambutol and pyrazinamide and its process of preparation
US9814680B2 (en) 2013-07-26 2017-11-14 Sanofi Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1217912A (en) * 1997-11-26 1999-06-02 岑冠新 Composite rifapentine preparation and preparing method therefor
PL355844A1 (en) * 2000-08-09 2004-05-31 Panacea Biotec Limited Novel pharmaceutical compositions of anti-tubrcular drugs and process for their preparation
WO2002087547A1 (en) * 2001-04-27 2002-11-07 Lupin Limited An improved process for preparation of four-drug anti-tubercular fixed dose combination
US20050059719A1 (en) * 2003-09-16 2005-03-17 Badawy Sherif Ibrahim Farag Solid dosage formulation containing a Factor Xa inhibitor and method
US7803838B2 (en) * 2004-06-04 2010-09-28 Forest Laboratories Holdings Limited Compositions comprising nebivolol
JPWO2007043452A1 (en) * 2005-10-12 2009-04-16 パイオニア株式会社 On-vehicle imaging device and imaging movable range measurement method of on-vehicle camera
CN1857280A (en) * 2006-04-11 2006-11-08 济南帅华医药科技有限公司 Slow released compound antituberculotic preparation
KR101197277B1 (en) * 2009-02-05 2012-11-05 (주) 벡스코아 Oral Solid Preparation For Treatment And Prevention Of Tuberculosis
US8470365B2 (en) * 2010-07-29 2013-06-25 Taiwan Biotech Co., Ltd. Process for preparation of anti-tubercular combination and pharmaceutical composition prepared therefrom

Also Published As

Publication number Publication date
ZA201600109B (en) 2017-04-26
SG11201510730UA (en) 2016-01-28
RU2682178C2 (en) 2019-03-15
HK1218862A1 (en) 2017-03-17
PE20160520A1 (en) 2016-05-31
CL2016000182A1 (en) 2016-06-24
CN105407875A (en) 2016-03-16
JP6461142B2 (en) 2019-01-30
WO2015011161A1 (en) 2015-01-29
IL243368A0 (en) 2016-02-29
TWI651084B (en) 2019-02-21
JP2016539109A (en) 2016-12-15
PH12016500120A1 (en) 2016-04-25
CA2918827A1 (en) 2015-01-29
EP3024443A1 (en) 2016-06-01
AU2014295098A1 (en) 2016-02-11
MX2016001154A (en) 2016-04-29
ECSP16005208A (en) 2017-02-24
TW201605442A (en) 2016-02-16
US20160158157A1 (en) 2016-06-09
RU2016106384A (en) 2017-08-29
AU2014295098B2 (en) 2019-07-11
RU2016106384A3 (en) 2018-05-31

Similar Documents

Publication Publication Date Title
EP2815746A4 (en) Saponin nano-micelle and preparation method, use and pharmaceutical composition thereof
IL271352B (en) Pharmaceutical composition comprising glutarimide derivatives and use thereof in the treatment of eosinophilic diseases
HK1221649A1 (en) Pharmaceutical tablet comprising acetylsalicylic acid and clopidogrel
IL243226A0 (en) Pyrazole derivatives, their preparation and pharmaceutical composition containing them
EP2995308A4 (en) Antihypoxic pharmaceutical composition and application thereof
IL243227A0 (en) Diaminocyclopentane carboxamide derivatives, their preparation and pharmaceutical composition containing them
HK1214519A1 (en) Dual use oral pharmaceutical composition tablets of sulfate saltes and methods of use thereof
RS60393B1 (en) Stable pharmaceutical compositions containing sitagliptin in the form of immediate release tablets
HK1222337A1 (en) Topical composition and carrier for administration of pharmaceutical or cosmetic active ingredients
EP3311809A4 (en) Use of pharmaceutical composition in preparation of drug for promoting chondrocyte generation
HK1218861A1 (en) Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
HK1218862A1 (en) Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
HUP1600414A2 (en) Stable pharmaceutical composition containing bisoprolol and ramipril
GB201307082D0 (en) Pharmaceutical composition comprising 15-HETrE and methods of using the same
MX2016006742A (en) Pharmaceutical composition.
HRP20180781T1 (en) Pharmaceutical composition comprising lacidipine and process of preparation
HK1219886A1 (en) Coated phenylephrine particles and use thereof in pharmaceutical formulations
TH1601000296A (en) Stable pharmaceutical composition against tuberculosis in the form of disintegrating tablets. rapidly comprising isoniazid granules and rifapentine granules and their preparation processes.